Tissue-Based Testing

News on immunohistochemistry and other tissue-based testing methods.

The Yale professor said that deep-learning algorithms could give digital pathology the push it needs for broader adoption.

The approval follows a validation study that included 3,300 cases and 6,600 FFPE glass slides at four sites in India.

Within the centralized and point-of-care solutions business, integrated serum work area solutions drove growth with immunodiagnostics sales rising 13 percent.

The financing follows a $5.15 million Series A round completed in 2015 and will go toward development and commercialization of Ultivue's InSituPlex technology. 

The firm's CEO said he's seeing significant growth in research applications from its RNA in-situ hybridization technology, and sees potential for its use in clinical settings.